Correlation Between Precision BioSciences and Carmell Therapeutics
Can any of the company-specific risk be diversified away by investing in both Precision BioSciences and Carmell Therapeutics at the same time? Although using a correlation coefficient on its own may not help to predict future stock returns, this module helps to understand the diversifiable risk of combining Precision BioSciences and Carmell Therapeutics into the same portfolio, which is an essential part of the fundamental portfolio management process.
By analyzing existing cross correlation between Precision BioSciences and Carmell Therapeutics, you can compare the effects of market volatilities on Precision BioSciences and Carmell Therapeutics and check how they will diversify away market risk if combined in the same portfolio for a given time horizon. You can also utilize pair trading strategies of matching a long position in Precision BioSciences with a short position of Carmell Therapeutics. Check out your portfolio center. Please also check ongoing floating volatility patterns of Precision BioSciences and Carmell Therapeutics.
Diversification Opportunities for Precision BioSciences and Carmell Therapeutics
0.77 | Correlation Coefficient |
Poor diversification
The 3 months correlation between Precision and Carmell is 0.77. Overlapping area represents the amount of risk that can be diversified away by holding Precision BioSciences and Carmell Therapeutics in the same portfolio, assuming nothing else is changed. The correlation between historical prices or returns on Carmell Therapeutics and Precision BioSciences is a relative statistical measure of the degree to which these equity instruments tend to move together. The correlation coefficient measures the extent to which returns on Precision BioSciences are associated (or correlated) with Carmell Therapeutics. Values of the correlation coefficient range from -1 to +1, where. The correlation of zero (0) is possible when the price movement of Carmell Therapeutics has no effect on the direction of Precision BioSciences i.e., Precision BioSciences and Carmell Therapeutics go up and down completely randomly.
Pair Corralation between Precision BioSciences and Carmell Therapeutics
Given the investment horizon of 90 days Precision BioSciences is expected to generate 0.59 times more return on investment than Carmell Therapeutics. However, Precision BioSciences is 1.69 times less risky than Carmell Therapeutics. It trades about -0.07 of its potential returns per unit of risk. Carmell Therapeutics is currently generating about -0.09 per unit of risk. If you would invest 807.00 in Precision BioSciences on August 31, 2024 and sell it today you would lose (76.50) from holding Precision BioSciences or give up 9.48% of portfolio value over 90 days.
| Time Period | 3 Months [change] |
| Direction | Moves Together |
| Strength | Significant |
| Accuracy | 95.65% |
| Values | Daily Returns |
Precision BioSciences vs. Carmell Therapeutics
Performance |
| Timeline |
| Precision BioSciences |
| Carmell Therapeutics |
Precision BioSciences and Carmell Therapeutics Volatility Contrast
Predicted Return Density |
| Returns |
Pair Trading with Precision BioSciences and Carmell Therapeutics
The main advantage of trading using opposite Precision BioSciences and Carmell Therapeutics positions is that it hedges away some unsystematic risk. Because of two separate transactions, even if Precision BioSciences position performs unexpectedly, Carmell Therapeutics can make up some of the losses. Pair trading also minimizes risk from directional movements in the market. For example, if an entire industry or sector drops because of unexpected headlines, the short position in Carmell Therapeutics will offset losses from the drop in Carmell Therapeutics' long position.| Precision BioSciences vs. Cue Biopharma | Precision BioSciences vs. Eliem Therapeutics | Precision BioSciences vs. Inhibrx | Precision BioSciences vs. Molecular Partners AG |
| Carmell Therapeutics vs. ZyVersa Therapeutics | Carmell Therapeutics vs. Sonnet Biotherapeutics Holdings | Carmell Therapeutics vs. Revelation Biosciences | Carmell Therapeutics vs. Quoin Pharmaceuticals Ltd |
Check out your portfolio center.Note that this page's information should be used as a complementary analysis to find the right mix of equity instruments to add to your existing portfolios or create a brand new portfolio. You can also try the Investing Opportunities module to build portfolios using our predefined set of ideas and optimize them against your investing preferences.
Other Complementary Tools
| Instant Ratings Determine any equity ratings based on digital recommendations. Macroaxis instant equity ratings are based on combination of fundamental analysis and risk-adjusted market performance | |
| Bonds Directory Find actively traded corporate debentures issued by US companies | |
| Competition Analyzer Analyze and compare many basic indicators for a group of related or unrelated entities | |
| Earnings Calls Check upcoming earnings announcements updated hourly across public exchanges | |
| Volatility Analysis Get historical volatility and risk analysis based on latest market data |